Optimising nicotine replacement therapy in clinical practice

Australian Family Physician

Volumn 42, Issue 5, 2013, Pages 305-309

  Mendelsohn, Colin ^a  

^a Australian Association of Smoking Cessation Professionals   (Australia)

Author keywords

Nicotine replacement products; Smoking cessation

Indexed keywords

NICOTINE GUM;

ARTICLE; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; SMOKING; SMOKING CESSATION; STANDARD;

HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 84878367998     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012, Issue 11. Art. No.: CD000146. DOI: 10.1002/14651858.CD000146.pub4.
2. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction 2008;103:1371-8.
3. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav 2011;36:713-6.
4. Beard E, McDermott M, McEwen A, West R. Beliefs of stop smoking practitioners in United Kingdom on the use of nicotine replacement therapy for smoking reduction. Nicotine Tob Res 2012;14:639-47.
5. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011;106:52-61.
6. Shiffman S, Rolf CN, Hellebusch S J, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002;97:505-16.
7. Shiffman S. Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 2007;102:809-14.
8. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. A double-blind trial of a nicotine inhaler for smoking cessation. JAMA 1993;10:1268-71.
9. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo- controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther 2008;30:1852-8.
10. Burns EK, Levinson AH. Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prev Med 2008;34:212-5.
11. Zwar N, Richmond R, Borland R, et al. Supporting smoking cessation: a guide for health professionals. South Melbourne: The Royal Australian College of General Practitioners, 2011.
12. Zwar N, Bell J, Peters M, Christie M, Mendelsohn C. Nicotine and nicotine replacement therapy-the facts. Pharmacist 2006;25:969-73.
13. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC four-country survey. Nicotine Tob Res 2011;13:94-102.
14. Henningfield J, Radzius A, Cooper TM, Clayton RR. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum. JAMA 1990;264:1560-64.
15. Tonnesen P, Lauri H, Perfekt R, Mann K, Batra A. Efficacy of a nicotine mouth spray in smoking cessation: a randomised double-blind trial. Eur Resp J 2012;40:548-54.
16. Hansson A, Perfekt R, Kraiczi H. Craving relief with a novel nicotine mouth spray form of nicotine replacement therapy. Poster presented at 17th Annual Meeting of the Society for Research on Nicotine and Tobacco, Toronto, Canada, February 16-19, 2011.
17. Shiffman S. Dresler C, Hajek P, et al. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002;162:1267-76.
18. Shiffman S, Sembower MA, Rohay JM, Gitchell JG, Garvey AJ. Assigning dose of nicotine gum by time to first cigarette. Nicotine Tob Res 2013;15:407-12.
19. Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005;57:79-115.
20. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease and therapeutics. Ann Rev Pharmacol Toxicol 2009;49:57-71.
21. Shah SD, Wilken LA, Winkler SR, Lin S-J. Systematic review and meta-analysis of combination therapy for smoking cessation. J Am Pharm Assoc 2008;48:659- 65.
22. Loh W-Y, Piper ME, Schlam TR, et al. Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy. Nicotine Tob Res 2012;14:131-41.
23. Fagerstrom KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nicotine Tob Res 2002;4:S73-9.
24. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation. Who will quit with and without the nicotine patch? JAMA 1994;271:589-94.
25. Hughes JR. Use of nicotine replacement after a smoking lapse. Nicotine Tob Res 2012;14:751-4.
26. Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol 2006;74:276-85.
27. Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction 2012;107:1349-53.
28. Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat 2009;36:235-43.
29. Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology 2003;166:343-50.
30. Durcan MJ, De'Ath J, Targett D, Marsh H, Chan R, Ong TJ. Efficacy of the nicotine lozenge in relieving cue provoked cravings. Presented at the Annual European meeting of the Society for Research on Nicotine & Tobacco, Padua, Italy. 2003.
31. U.S. Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010.
32. Kozlowski LT, Giovino GA, Edwards B, et al. Advice on using over-the-counter nicotine replacement therapy-patch, gum, or lozenge-to quit smoking. Addict Behav 2007;32:2140-50.
33. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, treating and preventing tobacco addiction. Clin Pharm Ther 2008;83:531-41.